Browse
Explore conditions, clinical trials, and the organisations running them.
Find a condition
Search the conditions that have clinical trials.
7531 conditions with clinical trials.
- Ovarian squamous cell carcinoma 2 trials · 2,845 incl. sub-types
- Larynx verrucous carcinoma 2 trials · 2,844 incl. sub-types
- Extraocular retinoblastoma 2 trials · 2,843 incl. sub-types
- Malignant ovarian Brenner tumor 2 trials · 2,842 incl. sub-types
- Ovarian clear cell malignant adenofibroma 2 trials · 2,842 incl. sub-types
- Malignant germ cell tumor of ovary 2 trials · 2,841 incl. sub-types
- Vulval Paget disease 2 trials · 2,841 incl. sub-types
- Stage II endometrioid carcinoma 2 trials · 2,840 incl. sub-types
- Orbit lymphoma 2 trials · 2,837 incl. sub-types
- Central neurocytoma 2 trials · 2,836 incl. sub-types
- Hereditary site-specific ovarian cancer syndrome 2 trials · 2,836 incl. sub-types
- Medium/large size posterior uveal melanoma 2 trials · 2,832 incl. sub-types
- Papillary adenocarcinoma 2 trials · 2,827 incl. sub-types
- Undifferentiated pleomorphic sarcoma, inflammatory variant 2 trials · 2,826 incl. sub-types
- Retroperitoneal leiomyosarcoma 2 trials · 2,823 incl. sub-types
- Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 3 2 trials · 2,822 incl. sub-types
- Posterior fossa group A ependymoma 2 trials · 2,822 incl. sub-types
- Large cell carcinoma 2 trials · 2,821 incl. sub-types
- Botryoid rhabdomyosarcoma 2 trials · 2,817 incl. sub-types
- Extraosseous osteosarcoma 2 trials · 2,815 incl. sub-types
- Medullary breast carcinoma 2 trials · 2,800 incl. sub-types
- Lung carcinoma in situ 2 trials · 2,799 incl. sub-types
- Sporadic breast cancer 2 trials · 2,795 incl. sub-types
- Multiple endocrine neoplasia type 2B 2 trials · 2,793 incl. sub-types
- Peritoneal serous adenocarcinoma 2 trials · 2,778 incl. sub-types
- Central nervous system germinoma 2 trials · 2,776 incl. sub-types
- Bowen disease of the skin 2 trials · 2,775 incl. sub-types
- Carcinoma of urethra 2 trials · 2,775 incl. sub-types
- Primary melanoma of the central nervous system 2 trials · 2,772 incl. sub-types
- SMARCB1-deficient kidney medullary carcinoma 2 trials · 2,771 incl. sub-types
- Hereditary papillary renal cell carcinoma 2 trials · 2,770 incl. sub-types
- Apocrine adenocarcinoma 2 trials · 2,769 incl. sub-types
- Sebaceous adenocarcinoma 2 trials · 2,769 incl. sub-types
- Myxoid chondrosarcoma 2 trials · 2,768 incl. sub-types
- Round cell sarcoma with EWSR1-non-ETS fusion 2 trials · 2,767 incl. sub-types
- Nonanaplastic kidney Wilms tumor 2 trials · 2,760 incl. sub-types
- Urethra squamous cell carcinoma 2 trials · 2,759 incl. sub-types
- Infiltrating renal pelvis/ureter urothelial carcinoma 2 trials · 2,758 incl. sub-types
- Heart cancer 2 trials · 2,755 incl. sub-types
- Pleural sarcomatoid mesothelioma 2 trials · 2,754 incl. sub-types
- Tall cell variant thyroid gland papillary carcinoma 2 trials · 2,753 incl. sub-types
- Paget disease 2 trials · 2,747 incl. sub-types
- Basaloid squamous cell carcinoma 2 trials · 2,743 incl. sub-types
- Hepatoid adenocarcinoma 2 trials · 2,741 incl. sub-types
- Mesonephric adenocarcinoma 2 trials · 2,741 incl. sub-types
- Mucoepidermoid carcinoma 2 trials · 2,741 incl. sub-types
- Malignant tumor of parathyroid gland 2 trials · 2,739 incl. sub-types
- Nasopharyngeal type undifferentiated carcinoma 2 trials · 2,739 incl. sub-types
- Malignant myoepithelioma 2 trials · 2,738 incl. sub-types
- Mixed testicular germ cell cancer 2 trials · 2,736 incl. sub-types